MESA LABORATORIES INC /CO/

For the period ended Sep 30, 2026. Filed Nov 9, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Nov 9, 2026

MLAB$127.82-0.3%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Balance Sheets

M****esa Laboratories, Inc.**

Condensed Consolidated Balance Sheets

(in thousands, except share amounts)

	September 30,	March 31,
	2026	2026
ASSETS
Current assets:
Cash and cash equivalents	$22,312	$26,928
Accounts receivable, less allowance for credit losses of $1,900 and $2,569, respectively	39,384	44,099
Inventories	26,550	26,373
Prepaid expenses and other current assets	10,001	8,868
Total current assets	98,247	106,268
Non-current assets:
Property, plant and equipment, net of accumulated depreciation of $31,612 and $30,115, respectively	29,345	30,613
Deferred tax assets	1,485	1,501
Other assets	19,909	19,155
Customer relationships, net	56,025	63,211
Other intangibles, net	17,488	20,136
Goodwill	185,236	186,863
Total assets	$407,735	$427,747
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$4,821	$4,928
Accrued payroll and benefits	11,802	19,006
Unearned revenues	14,007	14,723
Other accrued expenses	15,325	17,616
Term loan, current portion	5,625	5,625
Total current liabilities	51,580	61,898
Non-current liabilities:
Deferred tax liabilities	19,924	20,085
Non-current operating lease liabilities	15,754	13,662
Term loan, non-current portion, net of debt issuance costs	58,631	61,357
Revolving line of credit	67,250	84,500
Total liabilities	213,139	241,502
Stockholders’ equity:
Common stock, no par value; authorized 25,000,000 shares; issued and outstanding, 5,613,964 and 5,524,931 shares, respectively	380,126	375,348
(Accumulated deficit)	(180,358)	(185,747)
Accumulated other comprehensive (loss)	(5,172)	(3,356)
Total stockholders’ equity	194,596	186,245
Total liabilities and stockholders’ equity	$407,735	$427,747

See accompanying notes to Condensed Consolidated Financial Statements.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.